Morphological Changes of Bones and Joints with Rheumatoid Arthritis and Osteoarthritis

  • Hong, Yun-Kyung (Department Rehabilitation Science in PhD Program Interdisciplinary, Inje University) ;
  • Javaregowda, Palaksha Kanive (Cardiovascular & Metabolic Disease Center, College of Biomedical Science & Engineering) ;
  • Lee, Sang-Kil (Cardiovascular & Metabolic Disease Center, College of Biomedical Science & Engineering) ;
  • Lee, Sang-Rae (National Primate Research Center, Korea Research institute of Biotechnology) ;
  • Chang, Kyu-Tae (National Primate Research Center, Korea Research institute of Biotechnology) ;
  • Hong, Yong-Geun (Department Rehabilitation Science in PhD Program Interdisciplinary, Inje University)
  • 투고 : 2011.06.01
  • 심사 : 2011.06.20
  • 발행 : 2011.06.30

초록

Arthritis is a common disease in aged people, and is clinically divided into rheumatoid arthritis (RA) and osteoarthritis (OA). Although common symptoms such as pain are present, the underlying pathological mechanisms are slightly different. Therefore, the objectives of the present study were to compare joint damage induced by RA and OA by analyzing the major morphological and molecular differences, and to propose a suitable therapeutic intervention based on the pathophysiological conditions of bones and joints. For the RA animal model, 8-week-old DBA1/J mice were immunized with bovine type II collagen emulsified in complete Freund's adjuvant (CFA). Normal C57BL/6 mice (over 2 years of age) were used for OA. The clinical arthritis score was calculated using a subjective scoring system, and paw thicknesses were measured using calipers. The serum TNF ${\alpha}$ level was analyzed using an ELISA kit. Micro-CT was used to identify pathological characteristics and morphological changes. In collagen-induced RA mice, there were increased ankle joint volumes and clinical scores (p<0.01). The concentration of TNF ${\alpha}$ was significantly increased from 3 to 7 weeks after immunization. Micro-CT images showed trabecular bone destruction, pannus formation, and subchondral region destruction in RA mice. OA among aged mice showed narrowed joint spaces and breakdown of articular cartilage. This study suggests that a careful therapeutic intervention between RA and OA is required, and it should be based on morphological alteration of bone and joint.

키워드

참고문헌

  1. Alonso-Ruiz A, Pijoan JI, Ansuategui E, Vrkaregi A, Calabozo M, Quintana A (2008): Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety. BMC Musculoskelet Disord 9:52. https://doi.org/10.1186/1471-2474-9-52
  2. Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B (2005): Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 64:1263-1267. https://doi.org/10.1136/ard.2004.025270
  3. Chen G (2010): Immunotherapy of rheumatoid arthritis targeting inflammatory cytokines and autoreactive T cells. Arch Immunol Ther Exp 58:27-36. https://doi.org/10.1007/s00005-009-0058-1
  4. Donate PB, Fomari TA, Junta CM, Magalhaes DA, Macedo C, Cunha TM, Nguyen C, Cunha FQ Passos GA (2010): Collagen induced arthritis (CLA) in mice features regulatory transcriptional network connecting major histocompatibility complex (MHC $H_2$) with autoantigen genes in the thymus. Immunobiology 216:591-603.
  5. Dentener MA, Wouters EF (2006): Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med 355:2047-2048.
  6. Feldmann M, Brennan FM, Maini RN (1996): Rheumatoid arthritis. Cell 85:307-310. https://doi.org/10.1016/S0092-8674(00)81109-5
  7. Goldring MB, Goldring SR (2010): Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci 1192:230-237. https://doi.org/10.1111/j.1749-6632.2009.05240.x
  8. Goldenberg DL, Egan MS, Cohen AS (1982): Inflammatory synovitis in degenerative joint disease. J Rheumatol 9:204-209.
  9. Goronzy JJ, Weyand CM (2009): Developments in the scientific understanding of rheumatoid arthritis. Arthritis Res Ther 11:249. https://doi.org/10.1186/ar2758
  10. Jakobsson U, Hallberg IR, Westergren A (2007): Exploring determinants for quality of life among older people in pain and in need of help for daily living. J Clin Nurs 16:95-104. https://doi.org/10.1111/j.1365-2702.2006.01584.x
  11. Lee DM, Kiener HP, Agarwal SK, Noss EH, Watts GF, Chisaka O, Takeichi M, Brenner MB (2007): Cadherin-11 in synovial lining formation and pathology in arthritis. Science 315:1006-1010. https://doi.org/10.1126/science.1137306
  12. Locksley RM, Killeen N, Lenardo MJ (2001): The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487-501. https://doi.org/10.1016/S0092-8674(01)00237-9
  13. Lories RJ, Luyten FP (2009): Bone morphogenetic protein signaling and arthritis. Cytokine Growth Factor Rev 20:467-473. https://doi.org/10.1016/j.cytogfr.2009.10.009
  14. Malfait AM, Williams RO, Malik AS, Maini RN, Feldmann M (2001): Chronic relapsing homologous collagen-induced arthritis in DBA/1 mice as a model for testing disease-modifying and remission-inducing therapies. Arthritis Rheum 44:1215-1224. https://doi.org/10.1002/1529-0131(200105)44:5<1215::AID-ANR206>3.0.CO;2-#
  15. McQueen FM (2007): A vital clue to deciphering bone pathology: MRI bone oedema in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 66:1549-1552. https://doi.org/10.1136/ard.2007.082875
  16. Murphy CL, Thoms BL, Vaghjiani RJ, Lafont JE (2009): Hypoxia. HIF-mediated articular chondrocyte function: prospects for cartilage repair. Arthritis Res Ther 11:213. https://doi.org/10.1186/ar2574
  17. Murphy G, Nagase H (2008): Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? Nat Clin Pract Rheumatol 4:128-135.
  18. Neogi T, Felson D, Niu J, Nevitt M, Lewis CE, Aliabadi P, Sack B, Tomer J, Bradley L, Zhang Y (2009): Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies. BMJ 339:28-44.
  19. Oehler S, Neureiter D, Meyer-Scholten C, Aigner T (2002): Subtyping of osteoarthritic synoviopathy. Clin Exp Rheumatol. 20:633-640.
  20. Ohno H, Uemura Y, Murooka H, Takanashi H, Tokieda T, Ohzeki Y, Kubo K, Serizawa I (2008): The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model. Eur J Immunol 38:283-291. https://doi.org/10.1002/eji.200737199
  21. Otero M, Goldring MB (2007): Cells of the synovium in rheumatoid arthritis. Chondrocytes. Arthritis Res Ther 9:220-242. https://doi.org/10.1186/ar2292
  22. Scanzello CR, Umoh E, Pessler F, Diaz-Tome C, Miles T, Dicarlo E, Potter HG, Mandl L, Marx R, Rodeo S, Goldring SR, Crow MK (2009): Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Osteoarthritis Cartilage 17:1040-1048. https://doi.org/10.1016/j.joca.2009.02.011
  23. Yelin E, Henke C, Epstein W (1987): The work dynamics of the person with rheumatoid arthritis. Arthritis Rheum 30:507-512. https://doi.org/10.1002/art.1780300504